Literature DB >> 12215719

Hormonal replacement therapy.

Regine Sitruk-Ware1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12215719     DOI： 10.1023/a:1020028510797

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  80 in total

Review 1.  Alternatives to the use of estrogen in postmenopausal women.

Authors:  J V Pinkerton; R Santen
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Authors:  C Rodriguez; A V Patel; E E Calle; E J Jacob; M J Thun
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

3.  Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  L Mosca; P Collins; D M Herrington; M E Mendelsohn; R C Pasternak; R M Robertson; K Schenck-Gustafsson; S C Smith ; K A Taubert; N K Wenger
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

4.  The time has come to stop letting the HERS tale wag the dogma.

Authors:  M E Mendelsohn; R H Karas
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

5.  Nestorone: a progestin with a unique pharmacological profile.

Authors:  N Kumar; S S Koide; Y Tsong; K Sundaram
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

6.  The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.

Authors:  O Ylikorkala; B Cacciatore; I Paakkari; M J Tikkanen; L Viinikka; J Toivonen
Journal:  Fertil Steril       Date:  1998-05       Impact factor: 7.329

7.  Metabolic influences on the action of estrogens: therapeutic implications.

Authors:  E Gurpide
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

8.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

Review 9.  [Topical hormonal treatment and urogenital atrophy].

Authors:  R Sitruk-Ware; J L Thomas
Journal:  Praxis (Bern 1994)       Date:  1997-08-13

10.  Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women.

Authors:  S S Yen; P L Martin; A M Burnier; N M Czekala; M O Greaney; M R Callantine
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958
View more
  11 in total

1.  An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

Authors:  J I Acosta; R Hiroi; B W Camp; J S Talboom; H A Bimonte-Nelson
Journal:  Brain Res       Date:  2013-01-16       Impact factor: 3.252

Review 2.  Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Brain Res       Date:  2013-02-16       Impact factor: 3.252

3.  A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.

Authors:  Joshua S Talboom; Elizabeth B Engler-Chiurazzi; Paul Whiteaker; Alain R Simard; Ronald Lukas; Jazmin I Acosta; Laszlo Prokai; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2010-09-19       Impact factor: 3.587

4.  Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo.

Authors:  Lifei Liu; Liqin Zhao; Hongyun She; Shuhua Chen; Jun Ming Wang; Charisse Wong; Kelsey McClure; Regine Sitruk-Ware; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2010-10-13       Impact factor: 4.736

5.  Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.

Authors:  Elizabeth Engler-Chiurazzi; Candy Tsang; Sean Nonnenmacher; Winnie S Liang; Jason J Corneveaux; Laszlo Prokai; Matthew J Huentelman; Heather A Bimonte-Nelson
Journal:  Neurobiol Aging       Date:  2009-11-02       Impact factor: 4.673

6.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

7.  A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.

Authors:  B Blair Braden; Madeline G Andrews; Jazmin I Acosta; Sarah E Mennenga; Courtney Lavery; Heather A Bimonte-Nelson
Journal:  Behav Brain Res       Date:  2016-06-28       Impact factor: 3.332

8.  Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal rats.

Authors:  Jazmin I Acosta; Loretta Mayer; Joshua S Talboom; Cynthia Zay; Melissa Scheldrup; Jonathan Castillo; Laurence M Demers; Craig K Enders; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2008-12-03       Impact factor: 3.587

Review 9.  Estradiol and cognitive function: past, present and future.

Authors:  Victoria N Luine
Journal:  Horm Behav       Date:  2014-09-07       Impact factor: 3.587

Review 10.  Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models.

Authors:  Heather A Bimonte-Nelson; Jazmin I Acosta; Joshua S Talboom
Journal:  Molecules       Date:  2010-08-31       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.